JANE STREET GROUP, LLC

Holdings History for Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Symbol: ELVN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	+0%	$1,570,353	101,971	+101,971	NEW	$15.40	Q4 2025
31 Dec 2025	put	0%	+0%	$217,140	14,100	+14,100	NEW	$15.40	Q4 2025
30 Sep 2025			-0%	$0	0	-56,981	-100%	$27.16	Q3 2025
30 Jun 2025		0%	+0%	$1,143,039	56,981	+27,630	+94%	$20.06	Q2 2025
31 Mar 2025		0%	+0%	$577,628	29,351	+29,351	NEW	$19.68	Q1 2025
31 Dec 2024			-0%	$0	0	-30,793	-100%	$27.16	Q4 2024
30 Sep 2024		0%	-0%	$786,453	30,793	-22,212	-42%	$25.54	Q3 2024
30 Jun 2024		0%	+0%	$1,238,727	53,005	+42,603	+410%	$23.37	Q2 2024
31 Mar 2024		0%	-0%	$182,971	10,402	-5,282	-34%	$17.59	Q1 2024
31 Dec 2023		0%	+0%	$217,067	15,684	+15,684	NEW	$13.84	Q4 2023
30 Sep 2023			-0%	$0	0	-10,531	-100%	$27.16	Q3 2023
30 Jun 2023		0%	-0%	$214,938	10,531	-7,913	-43%	$20.41	Q2 2023
31 Mar 2023		0%	+0%	$403,924	18,444	+18,444	NEW	$21.90	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.